Ligand validation:4UC3

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 4UC3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4UC3_OLC_B_201	32%	53%	0.188	0.86	0.68	1.11	1	2	2	0	100%	1
4UC3_OLC_A_201	20%	56%	0.223	0.825	0.74	0.94	1	1	3	0	100%	1
4UC3_OLC_A_202	10%	54%	0.251	0.757	0.75	1.04	1	1	4	0	100%	1
5DUO_OLC_A_201	47%	52%	0.162	0.901	0.78	1.08	1	2	3	0	100%	1
4UC1_OLC_C_201	32%	54%	0.143	0.821	0.65	1.12	1	2	1	0	96%	0.96
8E7W_OLC_C_202	19%	54%	0.19	0.793	0.66	1.09	1	2	0	0	96%	0.96
8E7X_OLC_A_202	19%	58%	0.22	0.815	0.67	0.93	1	1	1	0	100%	1
4UC2_OLC_B_203	14%	56%	0.294	0.849	0.7	0.99	1	2	0	0	100%	1
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	63%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	59%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	54%	0.146	0.929	0.69	1.07	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.